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ABSTRACT Calcium/calmodulin (Ca/CaM) binds to the intracellular juxtamembrane domain (JMD) of the epidermal growth
factor receptor (EGFR). The basic JMD also binds to acidic lipids in the inner leaﬂet of the plasma membrane, and this interaction
may contribute an extra level of autoinhibition to the receptor. Binding of a ligand to the EGFR produces a rapid increase in intra-
cellular calcium, [Ca2þ]i, and thus Ca/CaM. How does Ca/CaM compete with the plasma membrane for the JMD? Does Ca/CaM
directly pull the JMD off the membrane or does Ca/CaM only bind to the JMD after it has dissociated spontaneously from the
bilayer? To answer this question, we studied the effect of Ca/CaM on the rate of dissociation of ﬂuorescent JMD peptides
from phospholipid vesicles by making kinetic stop-ﬂow measurements. Ca/CaM increases the rate of dissociation: an analysis
of the differential equations that describe the dissociation shows that Ca/CaM must directly pull the basic JMD peptide off the
membrane surface. These measurements lead to a detailed atomic-level mechanism for EGFR activation that reconciles the
existence of preformed EGFR dimers/oligomers with the Kuriyan allosteric model for activation of the EGFR kinase domains.INTRODUCTION
The epidermal growth factor receptor (EGFR/ErbB/HER)
family of receptor tyrosine kinases has been discussed in
many authoritative reviews that highlighted the growing
interest in this receptor’s mechanism of action in terms of
both cell biology and clinical utility (1–6). There is clinical
interest because mutations and deletions in the EGFR family
are associated with a variety of human cancers, and drugs
that interact specifically with these receptors are in clinical
use (7–10). Its relevance to cell biology is of interest because
the EGFR is the starting point for several different, well-
studied cell signaling pathways, such as the calcium/phos-
phoinositide pathway through the activation of PLC-g, the
PIP3 pathway through activation of PI3K, and the Ras/
MAP-kinase pathway.
Fig. 1 summarizes one current model of EGFR activation
adapted from similar figures in the literature (6,11–13). The
figure incorporates two recent advances in our understanding
of how binding of EGF leads to transautophosphorylation of
tyrosine residues in the C-terminal tail of the EGFR, and the
subsequent activation of downstream signaling pathways.
First, structural studies have revealed that the binding of
a ligand to the ‘‘tethered’’ extracellular domain of the
EGFR produces a conformational change that exposes the
dimerization arm (6,13,14). In the conventional paradigm,
shown in Fig. 1, the exposed arm allows two EGFR mono-
mers to form a dimer when they diffuse together. This brings
the two kinase domains into physical proximity. Second, an
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0006-3495/09/06/4887/9 $2.00elegant report from the Kuriyan laboratory revealed how one
kinase domain in a dimer activates its immediate neighbor
by an allosteric mechanism (12). Specifically, when the
C-terminal or large lobe of one EGFR kinase domain binds
to the N-terminal lobe of the other (see Fig. 1, right), it acti-
vates the second kinase by changing the structure of its
activation loop. This allosteric mechanism, for which there
is much experimental support, is described in detail else-
where (6,12,13,15–17).
The available data suggest that the juxtamembrane domain
(JMD), located between the transmembrane (TM) helix
(purple in Fig. 1) and the structured kinase domain (green
in Fig. 1), is natively unfolded or intrinsically disordered. It
is conventionally shown as a flexible ‘‘string’’ in the cyto-
plasm (indicated by the black wavy line in Fig. 1). If the role
of a ligand, such as EGF, is to cause the extracellular domains
of two EGFR monomers to bind and thus bring together the
intracellular kinase domains (as shown in Fig. 1, right), the
flexible nature of the JMD extending into the cytoplasm is
an asset. However, many experiments (18–23), including
single-molecule (22,24) and fluorescence correlation spec-
troscopy measurements on living cells (25,26), strongly
suggest that a fraction of the EGFR in the plasma membrane
exists as preformed dimers, or oligomers (27–30) in the
absence of a ligand. A fraction of the preformed dimers may
comprise the high-affinity class of EGFRs (18,23,27), which
appear to control the early response of the EGFR to EGF
(31,32). This leads to an apparent paradox in terms of the
model shown in Fig. 1. Why are the kinase domains of these
preformed dimers not active in the absence of ligands? Specif-
ically, if the JMD is flexible and free in the cytoplasm, why
should the allosteric mechanism shown in the right-hand panel
doi: 10.1016/j.bpj.2009.03.027
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activation based on similar figures in previous studies
(6,12,13,15). Binding of a ligand to the EGFR exposes
a dimerization arm; lateral diffusion and binding of dimer-
ization arms result in formation of a dimer. This allows the
C-terminal or large lobe of one kinase domain to bind to the
N-terminal lobe of the adjacent kinase domain and activate
it by an allosteric mechanism (12). The activated kinase
then phosphorylates tyrosine residues in the C-terminal
tail region of the adjacent EGFR. The JMD is assumed to
be free, flexible, and extended into the cytoplasm. An alter-
native ‘‘twist’’ model for activation (not shown) assumes
that binding of EGF to each EGFR in a preformed dimer
causes a rearrangement of the complex, perhaps a relative
rotation of subunits (see text for discussion). The extracel-
lular region of EGFR (orange), TM helix (purple), natively
unfolded JMD (black line), kinase domain (green), and
C-terminal tail (black) including tyrosine (dark blue
circles) or phosphotyrosine (orange) residues are shown.of Fig. 1 not always be operative for the preformed dimers?
Perhaps there is an additional level of autoinhibition, other
than the one exerted by the activation loop, that could explain
why preformed dimers or oligomers are not always active. In
other families of receptor tyrosine kinases, the JMD often
exerts such an additional autoinhibitory role (11). We consider
one specific autoinhibition mechanism in the Discussion
section (see Fig. 5). We postulate that the positively charged
JMD binds to the negatively charged inner leaflet, as does
the positive face of the kinase domain (33–35). This prevents
the two kinase domains from interacting, even if a significant
fraction of EGFRs exist as preformed dimers or oligomers.
Our model allows the well-supported allosteric mechanism to
be extended to the case of preformed dimers. In our model, the
binding of EGF to the preformed dimer of EGFR produces two
effects that contribute to activation. First, EGF reorganizes the
preformed dimer (the implications of which are discussed
below). Second, it produces a well-documented rapid increase
in the cytoplasmic concentration of calcium ions, [Ca2þ]i, which
causes an increase in the local concentration of calcium/calmod-
ulin (Ca/CaM). Calcium signaling is reviewed in detail else-
where (36). The total concentration of calmodulin in a typical
mammalian cell is in the range 20–50 mM (37,38). An increase
in Ca/CaM allows it to bind to the JMD and reverse its charge
from þ8 to 8. This repels the Ca/CaM-JMD complex from
the negatively charged inner leaflet of the plasma membrane;
the adjacent kinase domain thus also moves off the membrane,
contributing to activation (see Fig. 5). We provide pharmacolog-
ical evidence elsewhere that Ca/CaMassists the process of trans-
autophosphorylation of EGFR (35). Thus, it is of interest to
understand the mechanism by which Ca/CaM competes with
a membrane surface for the basic JMD of the EGFR, a known
Ca/CaM-binding site in this receptor.
We envision two possible kinetic mechanisms by which
Ca/CaM could enhance the fraction of time the JMD spends
desorbed from the membrane, and thus enhance the activa-
tion of the EGFR. First, Ca/CaM could lurk in the cytoplasm,
waiting for the JMD to spontaneously dissociate from theBiophysical Journal 96(12) 4887–4895membrane, and then bind rapidly to it. Second, Ca/CaM
could rip the membrane-bound JMD region from the
plasma membrane, increasing the rate of JM domain dissoci-
ation from the surface. We performed experiments with
fluorescently labeled peptides corresponding to the calmod-
ulin-binding portion of the JMD, EGFR(645–660), and
phospholipid vesicles of defined composition to distinguish
between these two possibilities, at least for the model system.
The cytoplasmic leaflets of mammalian plasma membranes
(39,40) contain 15–25% monovalent acidic lipids, mainly
phosphatidylserine (PS), and 1–3% polyvalent acidic lipids,
mainly phosphatidylinositol 4,5-bisphosphate (PIP2). The
EGFR JMD peptides bind with increasing avidity to phospho-
lipid vesicles as the mole fractions of PS and PIP2 are
enhanced. In the Discussion section we extrapolate these
measurements to the living cell and suggest that the binding
of the JMD of the EGFR to the inner leaflet of the plasma
membrane may be very strong in a quiescent cell. We specu-
late that Ca/CaM can only compete successfully with the
membranewhen ligand-induced reorganization of a preformed
EGFR dimer forces two JMDs, each with a charge of z¼þ8,
close together on the membrane surface. Close proximity of
the JMDs both weakens their membrane binding and electro-
statically attracts the negatively charged (z ¼ 16) Ca/CaM.
MATERIALS AND METHODS
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (PC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphatidylserine (PS), 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3- phosphatidyl-ethanolamine (PE), 1-oleoyl-2[12[7-nitro-2,1,3-benzox-
adiazol-4-yl)amino]dodecanoyl]-sn-glycero-3-phospho-L-serine (NBD-PS),
brain phosphatidylinositol 4,5-bisphosphate (PIP2), and cholesterol were
obtained from Avanti Polar Lipids (Alabaster, AL). Bovine brain calmodulin
(phosphodiesterase 30,50-cyclic nucleotide-activator) was obtained from
Sigma-Aldrich (St. Louis, MO). Acrylodan was purchased from Invitrogen
(Carlsbad, CA).
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acrylodan-CRRRHIVRKRTLRRLLQ. The acrylodan is attached covalently
to the extra Cys residue added to the N-terminus of the peptide, which corre-
sponds to the N-terminal, calmodulin-binding region of the JMD of the
EGFR. The N- and C-terminal ends of the peptide are blocked with acetyl
and amide groups, respectively. The peptide was obtained from American
Peptide (Sunnyvale, CA). The acrylodan label was covalently attached to
the Cys residue of the peptide at the NH2 terminus (see Methods in the Sup-
porting Material). The standard buffer solutions contained 100 mM KCl,
10 mM MOPS, pH ¼ 7.0. Vesicle preparation and experiments were done
at room temperature (22C). Large unilamellar vesicles (LUVs) of diameters
100 and ~300 nm were prepared as described elsewhere (41).
Kinetic measurements
Fig. S1 illustrates the experimental protocol used to study the calmodulin-
induced dissociation of acrylodan-EGFR(645–660) from vesicles, as docu-
mented in Figs. 2–4. As shown in Fig. 2 A, we measured the increase in
fluorescence that occurred when the peptide moved from vesicles to calmodulin
(excitation at 372 nm and emission at 466 nm). We designed the experiments so
that most of the peptide was initially bound to the vesicles; after mixing with
calcium/calmodulin (Ca/CaM), most of the peptide was bound to Ca/CaM.
RESULTS
The EGFR(645–660) peptide associates
with LUVs with a rate constant, kon, close
to the diffusion-limited value
The kinetics of EGFR(645–660) association with membranes
can be deduced by following the change in the fluorescence of
an attached acrylodan probe. When acrylodan inserts into the
low dielectric interior of the membrane, the fluorescence
increases and is blue-shifted. As described in Section 1 of
the Supporting Material, we determined the value of kon by
mixing acrylodan-labeled EGFR(645–660) and PC/PS vesi-
cles and experimentally determining the relaxation time, t,
of their interaction. A plot of the reciprocal of the relaxation
time (1/t) against vesicle concentration, [V], yields the
forward rate constant, kon:
1=t ¼ kon½V þ koff : (1)
We conclude for the EGFR(645–660) peptide, as for the
other basic/unfolded peptides we have examined, that the
forward rate constant does not differ significantly from
the diffusion-limited value, kdiff (41,42). For 100 nm vesi-
cles, this value is kon ~ kdiff ¼ ~1  1011 M1s1. (As we
discuss in Section 2 and Section 7 of the Supporting Mate-
rial, the EGFR(645–660) peptide also associates with
Ca/CaM with a rate constant close to the diffusion-limited
value of ~1  109 M1 s1, a result that is consistent with
more detailed kinetic studies of the binding of Ca/CaM to
other short peptides (43–45).
Ca/CaM increases the rate at which EGFR
(645–660) dissociates from PC/PS membranes
Here we report kinetic measurements that address the ques-
tion, Does Ca/CaM rip the JMD peptide off the membrane?
Fig. S1 illustrates the experimental protocol.The results shown in Fig. 2 A report measurements done
on 100 nm diameter PC/PS LUVs with 15% PS. We chose
conditions (e.g., lipid concentration) under which >90% of
the peptide is bound initially to the vesicles. The vesicles
contain 1% NBD-PS, which quenches the fluorescent probe
acrylodan that is attached covalently to the N-terminal region
of the peptide.
FIGURE 2 Ca/CaM enhances the rate of desorption of the EGFR JMD
peptide from a PC/PS vesicle. (A) Kinetics of the transfer of acrylodan-
EGFR(645–660) from PC/PS vesicles (15% PS) to Ca/CaM. Vesicles
with membrane-bound peptide were mixed rapidly with a solution contain-
ing CaM to obtain a final Ca/CaM concentration in the mixing chamber of
0.5 mM (triangles) or 4 mM (squares). The experimental data points are the
average of 10 shots. The curves are the single exponential fits to the data.
Note that increasing [Ca/CaM] from 0.5 to 4 mM decreases the relaxation
time constant ~4-fold. Additional experimental details are in the Methods
section of the Supporting Material. (B) The reciprocal of the time constant
(1/t) obtained from experiments shown in A and similar experiments is
plotted versus [Ca/CaM] in the final mixing chamber. Note that both the
intercept and slope increase as the mole fraction of PS in the vesicles
decreases. The intercept is one measure of the spontaneous dissociation
rate of the peptide from the vesicle; the slope is a measure of the transfer
rate constant between the vesicle and Ca/CaM. The average values of these
parameters are reported in Table 1.Biophysical Journal 96(12) 4887–4895
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mixed with a solution containing Ca/CaM (final [Ca/CaM]
¼ 0.5 mM in the mixing chamber; triangles in Fig. 2 A), the
peptide desorbs from the vesicles and binds to Ca/CaM,
causing the fluorescence to increase ~4-fold. (Section 3 of
the Supporting Material contains a discussion of the equilib-
rium affinity of the peptide for both membranes and Ca/CaM,
and the effect of the acrylodan probe on these affinities.)
At a final [Ca/CaM] ¼ 0.5 mM, the time constant (t) for
the movement of the peptide from vesicle to Ca/CaM is t
~ 200 ms. The value of 1/t ¼ 5 s1 is plotted in Fig. 2 B
on the graph of 1/t vs. [Ca/CaM]. This value is not much
faster than the spontaneous rate of dissociation of the peptide
from the vesicle (obtained by extrapolation of the line in
Fig. 2 B to [Ca/CaM] ¼ 0, and by independent measurements
discussed in Section 4 of the Supporting Material).
When the [Ca/CaM] in the mixing chamber is increased
from 0.5 to 4 mM (squares in Fig. 2 A), the time constant
for movement of the peptide from the vesicle to Ca/CaM
decreases from 200 to ~45 ms. Equivalently, the rate at which
the peptide moves off the membrane increases from 1/t ¼
5 s1 to 20 s1. This number is also plotted in Fig. 2 B. The
ability of Ca/CaM to enhance the rate at which the peptide
desorbs from the vesicles under our experimental conditions
strongly suggests that Ca/CaM is ripping the peptide off the
membrane in some manner, rather than just binding peptide
that desorbs spontaneously with a fixed rate. A detailed anal-
ysis of the differential equations that describe the relaxation
allows us to make this assertion (see Section 7 of the Support-
ing Material for a discussion of the expected results if Ca/CaM
had not been able to rip the peptide from the surface).
Control measurements show that when vesicles with
membrane-bound peptide are mixed with buffer solution that
lacks either calcium ions or calmodulin (circles in Fig. 2 A),
the peptide does not desorb significantly and the fluorescence
does not increase.
The rate of dissociation of EGFR(645–660)
from a vesicle is proportional to the [Ca/CaM]
Measurements similar to those in Fig. 2 A were repeated with
different concentrations of Ca/CaM, and the results are
plotted as open circles in Fig. 2 B. Note that the rate at which
the peptide desorbs from the vesicle in the presence of Ca/
CaM, 1/tCaM, is proportional to the [Ca/CaM]. The slope of
the curve may be defined as the transfer rate constant, ktrans,
which is 5  106 M1s1 for the vesicles with 15% PS. The
intercept of the line may be regarded as the spontaneous
rate at which the peptide dissociates from the surface (koff ¼
3 s1 for this particular set of measurements). This result
was averaged with the results of two other sets of independent
measurements for 15% PS vesicles, and the average values of
the intercept (koff¼ 5 s1) and slope (ktrans¼ 6 106 M1s1)
are given in Table 1. The numbers are reported as the
average5 SD for n ¼ 3 sets of independent measurements.Biophysical Journal 96(12) 4887–4895The transfer rate constant increases 10-fold
as the mole fraction of PS in the membrane
decreases from 17% to 10%
Fig. 2 B shows that as the mole fraction of PS in the vesicles
decreases, the transfer rate constant (slope) increases
~10-fold. This is shown more directly in Fig. 3, which plots
the value of ktrans for the EGFR(645–660) peptide versus the
mole fraction of PS in the vesicle. We define this process
more precisely in Section 7 of the Supporting Material, where
we present an analysis of the set of three coupled equations that
describe the interaction of Ca/CaM, EGFR(645–660) and the
membrane. The forward rate constant for the reaction between
Ca/CaM and the membrane-bound peptide is defined as k3 in
Eq. S3. Fig. 3 shows that the transfer rate constant for
EGFR(645–660), deduced from the slopes of lines in Fig. 2
B, is similar to the value of k3, deduced from an analysis of
the differential equations that describe the relaxation process,
and their best fit to the kinetic data. Fig. 3 also shows that the
transfer rate constant is identical, within experimental error,
for a completely different peptide, MARCKS(151–175), that
binds ~100-fold more strongly to Ca/CaM and a 5:1 PC/PS
vesicle. A possible interpretation of this somewhat surprising
result is discussed in Section 8 of the Supporting Material.
FIGURE 3 Transfer rate constant, ktrans (slope of the curves in Fig. 2 B),
increases as the mole % PS in the membrane decreases. Data for EGFR(645–
660) from Table 1 are shown as open triangles; data for MARCKS(151–175)
peptide are shown as open circles. The rate constants for the interaction
between Ca/CaM and the membrane-bound peptide, k3 (see Section 7 of
the Supporting Material), as calculated for EGFR(645–660) are shown as
solid triangles; data for MARCKS(151–175) peptide are shown as solid
circles.
TABLE 1 Dissociation and transfer rate constants of
EGFR(645–660) from PC/PS vesicles
% PS koff (s
1) ktrans106 (M1s1)
17 35 2 35 1
15 55 2 65 1
12 105 5 105 0.5
10 195 5 435 1.5
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of EGFR(645–660) from PC/PS vesicles
also increases ~10-fold as the mole fraction
of the acidic lipid PS decreases from 17% to 10%
We previously showed that the binding affinity (molar parti-
tion coefficient, K) of the EGFR(645–660) peptide to PC/PS
vesicles increases exponentially with the mole fraction of
monovalent acidic lipid (see Fig. S1 of McLaughlin et al.
(33)). This is expected theoretically (46) and was observed
experimentally with other basic and basic/hydrophobic
peptides (e.g., see Rusu et al. (47)). Thus, if the forward
rate constant, kon, is diffusion-limited and independent of
the binding affinity, increasing the mole fraction of PS,
which increases K ¼ kon/koff, should decrease koff. All the
data we have obtained are consistent with this prediction
(see Table 1 and Section 4 of the Supporting Material).
The transfer rate constant is independent
of the salt concentration
Fig. S9 shows that the transfer rate constant is independent of
the salt concentration, at least in the range of 50–150 mM
salt. In contrast, the molar partition coefficient K of the
peptide onto the vesicles (the reciprocal of the lipid concen-
tration required to bind 50% of the peptide) decreases mark-
edly as the salt concentration is increased, as expected for
electrostatic interactions (48,49). For example, K for the
interaction of EGFR(645–660) with 2:1 PC/PS vesicles
decreases 100-fold as the salt concentration increases from
100 to 200 mM (33). Thus, we anticipated that the rate
constant for spontaneous movement of the peptide off the
vesicle, koff ¼ kon/K, would also increase as the salt concen-
tration increases (because the diffusion-limited value of kon
should be independent of salt). Fig. S9 shows that koff does
increase as the salt concentration increases.
Incorporation of a physiological level of PIP2
into PC/PS vesicles decreases the rate at which
Ca/CaM can remove EGFR(645–660) from a vesicle
Fig. S4 shows that incorporating even a very low fraction of
the multivalent acidic lipid PIP2 into a PC/PS vesicle greatly
decreases the rate at which Ca/CaM can rip the peptide from
the membrane (i.e., incorporating 0.3% PIP2 produces an
order-of-magnitude decrease). The inner leaflet of a plasma
membrane contains both monovalent acidic lipids, such as
PS, and multivalent phosphoinositides, such as PIP2, which
typically comprises 1–3% of the phospholipids on the inner
leaflet (50). Previous work showed that the membrane-
adsorbed basic EGFR(645–660) peptide produces a local
positive electrostatic potential that acts as a basin of attraction
for multivalent phosphoinositides (51). The simple interpreta-
tion of the results shown in Fig. S4 is that PIP2 is concentrated
by nonspecific electrostatics adjacent to the membrane-
adsorbed basic peptide, which greatly decreases the ability
of Ca/CaM to rip the peptide off the surface.Increasing the surface density of basic peptides
adsorbed to a membrane to the point where
the peptides repel each other increases both
the spontaneous rate of desorption
and the rate at which Ca/CaM can remove
the EGFR(645–660) peptide
If binding of the JMD and kinase domain to the inner leaflet
of the plasma membrane effectively inactivates the EGFR by
preventing the two kinase domains from contacting each
other (see Discussion for a figure that illustrates how this
may occur), how does the allosteric activation mechanism
proposed by Kuriyan and co-workers (12) ever function?
We consider here a corollary of the rotation model for acti-
vation of preformed dimers (19,52). Specifically, we assume
that when two constituent EGFR monomers in a preformed
dimer bind EGF and rotate, this brings together the
membrane-bound JMD regions (e.g., Fig. 5). Simple electro-
static theory (53) indicates that pushing together the two þ8
basic regions will cause one to spontaneously dissociate
more rapidly from the membrane (koff increases). Further-
more, the rate at which Ca/CaM can remove one basic
JMD from the surface should also increase.
To study this phenomenon in a model system, we first
enhanced the number of EGFR(645–660) peptides bound
to a unit area of PC/PS membrane (i.e., increased the bound
peptide/lipid ratio). When the peptides are closer on average
than 2 Debye lengths (1/k ~1 nm) on the membrane, they
repel each other electrostatically. We expected this repulsion
to increase both the spontaneous rate of dissociation, koff, and
the rate at which Ca/CaM desorbs the peptide, ktrans, and that
is what we observed (data not shown). However, the analysis
is complicated because as Ca/CaM removes the peptide from
the membrane, the surface coverage or number of peptides/
area decreases, as does the phenomenon. To study the
phenomenon under conditions in which the analysis is
simpler, we added to the membrane extra basic clusters
that are not removed by Ca/CaM. Specifically, we added
a myristoylated peptide corresponding to the 18 N-terminal
residues of Src (myristoylated-Src(2-19) ¼ myr-Src peptide)
to a PC/PS vesicle. The myr-Src peptide has a net charge of
þ5 (54). Control electrophoretic mobility measurements
show that adding micromolar concentrations of the myr-
Src peptide to the aqueous phase does allow the myr-Src
peptide to bind to a degree that significantly reduces the
net charge density of the PC/PS vesicles (17% PS) that we
use for kinetic measurements. Specifically, the z-potential
of a 5:1 PC/PS vesicle changes from 27 5 1 mV to
0 mV upon addition of 1 mM myr-Src peptide, and to þ75
1 mV upon addition of 3 mM myr-Src peptide. (The z-poten-
tial is proportional to the net charge/area on the membrane
under our conditions.) Furthermore, Ca/CaM does not bind
significantly to this myr-Src peptide under our conditions
(adding Ca/CaM does not produce further changes in the
z-potential). Thus, we can study how Ca/CaM pulls theBiophysical Journal 96(12) 4887–4895
4892 Sengupta et al.EGFR(645–660) peptide off the membrane when this
peptide is adjacent to the myr-Src basic peptide (which is
present at a high surface concentration of ~3 myr-Src
peptides/100 lipids when the aqueous phase contains 1 mM
peptide.). A molecular model of this myr-Src peptide ad-
sorbed to a PC/PS bilayer is shown in Fig. 1 of Murray
et al. (54). The results are shown in Fig. 4 for PC/PS
membranes that contain 17% PS. The upper panel of
Fig. 4 shows the results when the Myr-Src peptide is absent.
Adding 3 mM Ca/CaM (final concentration in the mixing
FIGURE 4 Binding of a myristoylated basic (net charge þ5) peptide
corresponding to the N-terminal 18-residue region of Src (myr-Src peptide)
to a PC/PS phospholipid vesicle increases the rate at which Ca/CaM can
dissociate the EGFR(645–660) peptide from the surface by 10-fold. Kinetics
for the transfer of acrylodan-EGFR(645–660) from vesicles with 17% PS to
3 mM Ca/CaM, with 0 (A), 0.5 mM (B), and 1 mM (C) myr-Src peptide also
present in the mixing chamber. The solid curves designated b show single
exponential fits with the following relaxation times: (A) t ¼ 100 ms, (B)
t ¼ 23 ms, and (C) t ¼ 13 ms. Additional experimental details are provided
in the Methods section of the Supporting Material.Biophysical Journal 96(12) 4887–4895chamber) pulls the peptide off the PC/PS vesicle with
a time constant of t ¼ 100 ms. Adding 0.5 mM (Fig. 4,
middle panel) or 1 mM (Fig. 4, bottom panel) myr-Src
peptide (final concentration in mixing chamber) decreased
the time constants to ~20 and 10 ms, respectively. Thus,
increasing the surface concentration of basic peptide can
produce an order-of-magnitude increase in the rate at which
Ca/CaM can pull the peptide off the surface. Put another
way, Ca/CaM can compete more effectively with the
membrane for the JMD when two basic regions are close
together. The potential physiological implications of this
result are discussed below.
DISCUSSION
Fig. 2 shows that Ca/CaM increases the rate of desorption of
the EGFR(645–660) peptide from a phospholipid vesicle.
The simplest interpretation is that Ca/CaM rips the peptide
off the membrane. This interpretation is confirmed by
a detailed analysis in Section 7 of the Supporting Material.
Ca/CaM is more effective at ripping the peptide off
a surface for membranes with a lower mole fraction of acidic
lipid. If the physiological mole fraction of PS is >20%,
however, Ca/CaM barely increases the spontaneous rate of
dissociation (Fig. 2 B), and addition of PIP2 further decreases
the rate (Fig. S4 and Fig. S5).
Equilibrium measurements with simple JMD peptides
(33) and reconstituted peptides corresponding to the TM þ
JMD regions of EGFR (34) are in accord with the kinetic
data reported here with EGFR(645–660) peptides adsorbed
to phospholipid vesicles. If we extrapolate these results to
the biological membrane, they suggest that the JMD of the
EGFR binds sufficiently strongly to the inner leaflet that it
rarely comes off the negatively charged membrane. Further-
more, even when the level of Ca/CaM increases to the
maximum physiological value (~10 mM), the available
kinetic and equilibrium data suggest that it cannot compete
with the strong electrostatic binding of an isolated JMD to
the membrane.
If the binding is so strong that the JMD (and attached
kinase domain) rarely come off the membrane, how is activa-
tion of the EGFR achieved? The results reported in Fig. 4
provide one clue. If two JMD peptides come close together
(or one comes close to another membrane-adsorbed basic
cluster, such as on the myr-Src peptide), both the sponta-
neous rate of desorption and the rate at which Ca/CaM can
remove the JMD peptide are greatly enhanced, as expected
from simple electrostatic considerations. We suggest that
a similar phenomenon may occur with EGFR in a living cell.
Model of EGFR activation
Our view of the structure of a single EGFR molecule in the
plasma membrane is shown in Fig. 5 A. The structural
domains of the EGFR are shown to scale. The figure
EGFR, Membranes, and Calmodulin: Kinetics 4893FIGURE 5 Proposed mechanism of activation of EGFR. (A) Proposed structure of an EGFR monomer in a quiescent cell. The extracellular domain has the
structure determined from x-ray analysis, as reviewed by Ferguson (6). The N-terminal portion of the intracellular JMD (residues 645–660 of the JMD), with
the eight basic residues shown in blue, is postulated to bind electrostatically to the inner leaflet of the plasma membrane. The basic face of the kinase domain
(see Fig. 2 of McLaughlin et al. (33)) for the electrostatic potential profile) is also postulated to bind to the negatively charged inner leaflet of the plasma
membrane, but less strongly than the JMD. For simplicity, the C-terminal tail of the EGFR is not shown. (B) View from the cytoplasm. Two monomers
form a dimer (of known extracellular structure) upon binding of EGF. Alternatively, binding of EGF mediates rotation of the subunits of a preformed dimer
to the same extracellular structure. We hypothesize that in either case the intracellular basic JM regions come into proximity. Calmodulin is shown in the
cytoplasm. (C) The electrostatic repulsion between the two highly charged JMDs weakens their attraction to the membrane. This causes one of the JMDs
and its associated kinase domain to dissociate. (D) Alternatively, and in addition to the spontaneous dissociation shown in panel C, Ca/CaM binds to one
of the JMD and rips it from the membrane, resulting in the conformation shown in panel E. The proximity of the second JMD greatly facilitates this process.
Our measurements are consistent with the hypothesis that Ca/CaM can only compete with the membrane for binding of the JM region when the two JMDs are
close together as in panel B. (E) Ca/CaM binding to the JMD of one of the EGFR molecules in a dimer causes it and the associated kinase region to dissociate
from the membrane. Activation of the kinase domain by an allosteric mechanism (12) can proceed from the conformations shown in either panel E or C. In
panel F, we assume activation proceeds from the conformation shown in panel C. (F) The N-terminal lobe (small lobe, colored green) binds to the C-terminal
lobe of the membrane-bound kinase domain and is activated by an allosteric mechanism (12).illustrates two key postulates concerning the positively
charged JMD that emerge from our measurements.
First, we postulate that both the positively charged JMD
and the positive face of the kinase domain are bound to the
inner leaflet of the plasma membrane. We assume this is
true for both monomeric EGFR and for both of the two
EGFR molecules in a preformed dimer that exists in the
absence of ligand. There is evidence from many different
laboratories that preformed dimers of EGFR exist in the
absence of ligands (18–23,25,26). There is also evidence
from cleverly designed molecular biology experiments that
binding of EGF causes rotation of the constituents of a pre-
formed EGFR dimer (19,52), and we suggest that this may
cause the two JM regions to come together as shown in
Fig. 5 B. (Alternatively, if two monomers are joined together
by the dimerization arms after two EGF ligands bind, or two
preformed dimers come together to form a tetramer (27), the
membrane-bound JMD could be positioned close together as
shown in Fig. 5 B).
Second, we postulate that if the two JMDs come within 2
Debye lengths of each other (Debye length ¼ 1/k ~1 nm in
physiological salt), they will significantly repel each other
and thus weaken their net interaction with the membrane.The spontaneous rate of desorption from the membrane,
koff, will increase. This is shown in Fig. 5 C, which indicates
that one JMD þ kinase domain has desorbed from the
surface spontaneously. In addition, when the [Ca2þ]i and
thus the concentration of Ca/CaM increases (which happens
rapidly after binding of EGF to the EGFR), Ca/CaM can bind
to one of the two adjacent membrane-bound JMD, as shown
by the arrow in Fig. 5 D, causing it to desorb more rapidly, as
shown in Fig. 5 E. Activation of a kinase domain by the
allosteric mechanism could proceed from either the situation
in Fig. 5 C (one JMD þ kinase domain spontaneously
desorbed) or Fig. 5 E (one JMD dissociated by Ca/CaM
and accompanied by the kinase domain moving off the
membrane). Fig. 5 F shows the activation process that
occurs after the spontaneous desorption shown in Fig. 5 C.
In Fig. 5 F, the C-terminal lobe of the membrane-bound
kinase domain is binding to and activating the N-terminal
lobe of the cytoplasmic kinase domain by the allosteric
mechanism described previously (12,55). Ca/CaM is shown
adjacent to the kinase domain to illustrate its relative size.
When bound to the JMD, as in Fig. 5 E, Ca/CaM could stabi-
lize the activation of the kinase by the allosteric mechanism
shown in Fig. 5 F.Biophysical Journal 96(12) 4887–4895
4894 Sengupta et al.This mechanism is speculative. However, it is specific and
has a number of corollaries that can be tested.
For example, increasing the ionic strength of the cyto-
plasm weakens the electrostatic interaction of the JMD
(and kinase domain) for the membrane (33). The strong
effect of salt in decreasing the electrostatic interaction of
clusters of basic residues with membranes is well understood
from the first principles of physics (48). Thus, we would
expect an increase in the ionic strength of the cytoplasm to
activate the EGFR in the absence of ligand; it does (56,57).
Furthermore, making the inner leaflet of the plasma
membrane less negatively charged by the addition of amphi-
pathic weak bases, such as sphingosine, to the bathing solu-
tion should activate the EGFR in the absence of ligands. This
should occur at the aqueous concentration of the weak base
(e.g., sphingosine) that reverses the net charge of a bilayer
(~2 mM); it does (58). Furthermore, all amphipathic weak
bases should have this effect. We have tested this prediction
for several weak bases and confirmed the prediction for all
the chemicals we investigated (35). In Section 10 of the Sup-
porting Material we discuss three other predictions of the
model shown in Fig. 5.
We note that there are three simple biophysical concepts
or ‘‘cheap tricks’’ (59) involved in the activation of the
EGFR in the model illustrated in Fig. 5: reduction of dimen-
sionality, electrostatics, and coincidence counting. Reduc-
tion of dimensionality is important because the JMD is
anchored to the membrane surface by the TM region and
experiences a 1000-fold higher local concentration of lipid
than if it were dissolved in the cytoplasm (60). Electrostatics
is important because it produces the main energy that
anchors the JMD and kinase domain to the membrane.
Finally, full activation of the EGFR in our model is observed
only when two phenomena occur together: 1), a ligand binds
to the extracellular region and brings the two basic JMD
together on the surface (Fig. 5 B); and 2), the level of
Ca/CaM rises in the cell, ripping the JMD off the membrane
(Fig. 5, D and E) and enhancing the time a kinase domain
spends off the membrane.
In addition to these biophysical cheap tricks, there are two
well-established major elements of the activation mechanism
involved in the model presented in Fig. 5: 1), the mechanism
by which EGF releases the tethered state (6) and allows
dimer formation or rearrangement within a preformed dimer;
and 2), the allosteric activation mechanism of the kinase
domain (12). These aspects of the overall activation mecha-
nism seem likely to be retained in any future model.
SUPPORTING MATERIAL
Methods, results, discussion, figures, a table, and references are available at
http://www.biophysj.org/biophysj/supplemental/S0006-3495(09)00769-3.
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